Lawyers USA Your Business Partner

Accutane litigation grows 

By: Correy Stephenson
Published: March 7, 2012

Tags: Accutane, drug litigation, multi-district litigation

After more than a decade, the litigation against Hoffman-LaRoche, the maker of the acne drug Accutane, continues to grow.

More than 7,000 cases are currently on file in multi-district litigation consolidated in New Jersey state court, and both sides continue to vigorously litigate with no settlement negotiations in sight.

New Jersey court upholds $25 million Accutane verdict 

Published: September 28, 2011

Tags: Accutane, IBD, inflammatory bowel disease

Denying a defense motion for remittitur or new trial, a New Jersey judge has affirmed a jury’s $25.16 million award to an Alabama man who suffered from inflammatory bowel disease as a result of taking the acne medication Accutane.

Accutane verdicts: $2 million for one plaintiff out of three 

By: Correy Stephenson
Published: April 22, 2011

Tags: Accutane, Crohn’s disease, drug litigation, failure to warn, Hoffman-LaRoche, IBD, inflammatory bowel disease

In a trio of cases tried together against Hoffman-LaRoche, the maker of Accutane, jurors awarded just one of the plaintiffs suffering from inflammatory bowel disease $2.1 million. 

Drug litigation in review 2010 

By: Tony Ogden
Published: January 4, 2011

Tags: Accutane, Allergan, antidepressant, Avandia, AztraZeneca, Botox, Botox litigation, Department of Justice, DOJ, epilepsy, failure to warn, GlaxoSmithKline, heart attack, hormone replacement therapy, hormone replacement therapy litigation, Johnson & Johnson, Levaquin, Neurontin, Paxil, Pfizer, Premarin, Prempro, Provera, Roche, Seroquel, Wyeth

Much like 2009, 2010 was a busy year for prescription drug suits.

Accutane suits pile up 

By: Correy Stephenson
Published: October 20, 2010

Tags: Accutane, product liability

Several hundred more lawsuits were filed recently in the New Jersey mass tort against Roche, the maker of acne drug Accutane, alleging that the company failed to adequately warn users of the potential for serious side effects including Crohn’s disease, ulcerative colitis and inflammatory bowel disease.

$10.5 million Accutane verdict reversed 

By: Correy Stephenson
Published: August 10, 2010

Tags: Accutane, inflammatory bowel disease, product liability

A trial judge improperly limited the defense’s evidence regarding the overall number of Accutane users, the New Jersey Appellate Division has ruled in reversing a $10.5 million verdict for the plaintiff.

Roche defendants move for settlement approval in Accutane suit 

By: Tony Ogden
Published: May 12, 2010

Tags: Accutane, medical malpractice, product liability

The makers of an acne drug at the heart of a medical malpractice and product liability suit have asked that their settlement with plaintiff Jason Peipert be approved.

Last defendant in long-running Accutane suit settles 

By: Pat Murphy
Published: April 21, 2010

Tags: Accutane

A nearly seven-year old suit over an acne medication is over. The last defendant in a Madison County, Illinois, product liability-medical malpractice case involving Accutane settled as it was set to go to trial on Monday.

N.J. jury awards $25 million to Accutane user with IBD 

By: Nora Tooher
Published: February 25, 2010

Tags: Accutane, inflammatory bowel disease, Roche Laboratories

In a retrial, a New Jersey jury has awarded $25.16 million – nearly 10 times the original award – to an Alabama man with inflammatory bowel disease.

Expert can’t testify about Accutane study 

By: Nora Tooher
Published: February 8, 2010

Tags: Accutane, causation, expert testimony, product liability

A plaintiff’s expert can’t testify regarding a study showing a link between the drug Accutane and depression, but may be able to testify on general causation, the New Jersey Appellate Division has ruled.